PLGA+Fe₃O₄+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells

Dayan Yang; Qiqing Chen; Min Zhang; Lin Xie; Yan Chen; Tingting Zhong; Fang Tian; Guiying Feng; Xiangxiang Jing; Ling Lin

doi:10.12659/AOT.933246

11 February 2022 : Original article

PLGA+Fe₃O₄+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells

Dayan Yang^1BCDEF, Qiqing Chen^1BCDF, Min Zhang^1BCDF, Lin Xie^1BCD, Yan Chen^1BCF, Tingting Zhong^1BCF, Fang Tian^1BC, Guiying Feng^1CF, Xiangxiang Jing^1ABEG*, Ling Lin^1ADF

DOI: 10.12659/AOT.933246

Ann Transplant 2022; 27:e933246

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 Evaluation for binding efficiency of PLGA+Fe3O4+PFP nanoparticles carried targeting CDDP with HNE1 cells (A) and HepG2 cells (B). Flow cytometry assay was conducted to examine targeting CDDP binding HNE1 or HepG2 cells. * P<0.05 vs targeting CDDP+PLGA+Fe3O4+PFP group. Microsoft Office PowerPoint/EXCELL 2010 (Redmond, WA, USA) was used to create images (n=6).

Back to the Article

PLGA+Fe₃O₄+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells

Your Privacy